MULTIDRUG RESISTANT VIVAX MALARIA: A MAJOR CAUSE OF MORBIDITY IN EARLY LIFE

MULTIDRUG RESISTANT VIVAX MALARIA: A MAJOR CAUSE OF MORBIDITY IN EARLY LIFE

Bibliografske podrobnosti
Main Authors:	Poespoprodjo, JR, Fobia, W, Kenangalem, E, Lampah, D, Hasanuddin, A, Warikar, N, Sugiarto, P, Tjitra, E, Anstey, N, Price, R
Format:	Conference item
Izdano:	2008

Podobne knjige/članki

Vivax malaria: a major cause of morbidity in early infancy.
od: Poespoprodjo, JR, et al.
Izdano: (2009)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
od: Poespoprodjo, JR, et al.
Izdano: (2014)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
od: Poespoprodjo, JR, et al.
Izdano: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
od: Tjitra, E, et al.
Izdano: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
od: Tjitra, E, et al.
Izdano: (2008)

Severe congenital malaria acquired in utero.
od: Poespoprodjo, JR, et al.
Izdano: (2010)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
od: Price, R, et al.
Izdano: (2007)

Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.
od: Poespoprodjo, JR, et al.
Izdano: (2011)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
od: Karyana, M, et al.
Izdano: (2008)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
od: Setyadi, A, et al.
Izdano: (2019)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
od: Poespoprodjo, J, et al.
Izdano: (2015)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant <it>Plasmodium vivax </it>and <it>Plasmodium falciparum</it>
od: Okoseray Maurits J, et al.
Izdano: (2008-08-01)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
od: Lampah, D, et al.
Izdano: (2011)

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.
od: Douglas, N, et al.
Izdano: (2013)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
od: Douglas, N, et al.
Izdano: (2014)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
od: Tjitra, E, et al.
Izdano: (2007)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
od: Agus Setyadi, et al.
Izdano: (2019-04-01)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
od: Kenangalem, E, et al.
Izdano: (2017)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
od: Leonardo, L, et al.
Izdano: (2022)

The anaemia of Plasmodium vivax malaria.
od: Douglas, N, et al.
Izdano: (2012)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
od: Price, R, et al.
Izdano: (2010)

Vivax malaria: neglected and not benign.
od: Price, R, et al.
Izdano: (2007)

Vivax malaria: neglected and not benign.
od: Price, R, et al.
Izdano: (2007)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
od: Kho, S, et al.
Izdano: (2018)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
od: Oyong, DA, et al.
Izdano: (2018)

Increased carboxyhemoglobin in adult falciparum malaria is associated with disease severity and mortality.
od: Yeo, T, et al.
Izdano: (2013)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
od: Douglas, NM, et al.
Izdano: (2020)

Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria.
od: Yeo, T, et al.
Izdano: (2013)

Multidrug Resistant Transfusion Vivax Malaria
od: Emiliana Tjitra, et al.
Izdano: (2018-11-01)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
od: Thriemer, K, et al.
Izdano: (2020)

Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation.
od: Anstey, N, et al.
Izdano: (2007)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
od: Hasugian, A, et al.
Izdano: (2007)

Early and late mortality after malaria in young children in Papua, Indonesia
od: Patriani, D, et al.
Izdano: (2019)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
od: Douglas, NM, et al.
Izdano: (2017)

Plasmodium malariae infection associated with a high burden of anemia: a hospital-based surveillance study
od: Langford, S, et al.
Izdano: (2015)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: a rising burden of Plasmodium vivax malaria
od: Poespoprodjo, JR, et al.
Izdano: (2019)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia.
od: Daniel A Lampah, et al.
Izdano: (2011-06-01)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
od: Yeo, T, et al.
Izdano: (2010)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
od: Leonardo, Leo, et al.
Izdano: (2022)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
od: Leo Leonardo, et al.
Izdano: (2022-09-01)